Literature DB >> 4372510

A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease.

M S Oh, H J Carroll, J E Clemmons, A H Vagnucci, S P Levison, E S Whang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4372510     DOI： 10.1016/0026-0495(74)90032-8

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism.

Authors:  U Kuhlmann; W Vetter; E Fischer; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1978-03-01

2.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

3.  Hypoaldosteronism without hyperkalemia.

Authors:  P Weidmann; C Beretta-Piccoli; Z Glück; G Keusch; F C Reubi; R De Châtel; C Cottier
Journal:  Klin Wochenschr       Date:  1980-02-15

Review 4.  [The renin-angiotensin system in diabetic patients].

Authors:  J Mann; E Ritz
Journal:  Klin Wochenschr       Date:  1988-09-15

Review 5.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

6.  Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.

Authors:  J P Radó
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

7.  Heterogeneous changes of serum potassium levels in NIDDM patients on oral glucose load.

Authors:  H Y Bae; H J Kim
Journal:  Korean J Intern Med       Date:  1992-01       Impact factor: 2.884
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.